16.27 USD
▲+0.48+6.20%
盘后 15.15 -1.12%
2026-08-03
市值
$1.89B
市盈率
—
EPS
-1.31
股息率
—
52 周区间
9.82 – 21.45
成交量
1.74M
Beta
0.98
目标价
27.14
52W 低 9.8252W 高 21.45
价格走势
公司简介
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Lim...